A 5-Year Retrospective, Observational Study Assessing Rheumatoid Arthritis Disease Outcome Measures to Characterize Systemic Lupus Erythematosus Burden in the USA.
Christopher F BellShirley P HuangLouise H YuMaral DerSarkissianGuillaume GermainAndrew L ConcoffCarlyne M AverellBernard RubinYuqian M GuMei Sheng DuhDaniel J WallacePublished in: Rheumatology and therapy (2022)
RA disease measure utilization in SLE was generally infrequent but increased over time. Pain Index and MD-HAQ were the most commonly applied cumulatively across 5 years of follow-up. The rationale for the increased use of these measures in SLE over time requires further exploration. In the absence of a clinically applicable SLE-specific measure, the use of RA measures, for example in conjunction with SLE measures, may provide an alternative approach for measuring disease activity, representing an opportunity to improve patient outcomes.
Keyphrases
- disease activity
- systemic lupus erythematosus
- rheumatoid arthritis
- rheumatoid arthritis patients
- ankylosing spondylitis
- juvenile idiopathic arthritis
- chronic pain
- pain management
- clinical trial
- cross sectional
- molecular dynamics
- risk factors
- interstitial lung disease
- spinal cord
- systemic sclerosis
- postoperative pain